arrow
M

Matteo Molica

azienda ospedaliera renato dulbecco
H指数:22
被引数:1,568

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical, genetic, and familial features of POT1 tumor predisposition syndrome

POT1肿瘤易感综合征的临床、遗传及家族特征

Cancer
IF5.1
2026-02-130
OAAI
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia

更正:CPX-351在60岁以下继发急性髓系白血病患者中的真实世界多中心疗效分析

2025-12-040
OAAI
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients

Gilteritinib在二线治疗后的有效性:一项关于171例复发/难治性FLT3突变急性髓系白血病患者的真实世界多中心研究

2025-11-010
OAAI
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia

真实世界多中心分析CPX-351在60岁以下继发性急性髓系白血病患者中的疗效

2025-10-260
OA
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues

CAR-T细胞疗法在B细胞急性淋巴细胞白血病中的应用:新兴数据与待解决问题

2025-09-230
OAAI
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study

莫美洛替尼在骨髓纤维化患者中的疗效:一项多中心研究的结果

2025-09-010
OAAI